TABLE 6

Lymphoma, Malignant Bone Disease, and Meningioma

StudyDesignPatients (n)PET/MRICancer typeIndicationTNM-stagingSuperiority
Heacock (69)Prospective28SimultaneousLymphomaStagingND
Eiber (79)Retrospective119SimultaneousMalignant bone diseaseStaging, restagingPET/MRI superior for allocation of bone lesions
Beiderwellen (80)Prospective67SimultaneousMalignant bone diseaseStaging, restagingND
Catalano (81)Prospective109SimultaneousMalignant bone diseaseStaging, restagingPET/MRI superior for bone lesion detection
Afshar-Oromieh (84)Prospective15SimultaneousMeningiomaStagingND
Total338
  • NS = nonsignificant; ND = no difference; — = not reported.